Stay updated with breaking news from Today Astrazeneca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Launch of 20 new medicines expected by 2030 Significant growth from existing oncology, biopharmaceuticals and rare disease portfolios Investing in disruptive innovation that will shape the future...
Among the companies with reports and trading updates today are AstraZeneca, Kingfisher, SSP Group, Pennon, CVS Group and Naked Wines.
Can a CEO be worth $9 billion? Without a clear succession plan, investors should prepare for further swings. Today AstraZeneca’s shares are worth nearly twice that amount, and the group has thrived thanks to blockbusters like breast cancer treatment Lynparza, and bold M&A, such as the $39 billion purchase of rare disease specialist Alexion in the middle of the pandemic.